Respiratory syncytial virus-specific T-cell receptor (RSV-specific TCR)

The Respiratory syncytial virus-specific T-cell receptor (RSV-specific TCR) is a critical component of the adaptive immune system's defense against RSV infection. Located on the surface of CD8+ cytotoxic T-lymphocytes, this receptor specifically recognizes viral peptides, such as those derived from the RSV nucleoprotein (N) or matrix (M) proteins, when they are presented by Major Histocompatibility Complex (MHC) class I molecules. This recognition event is essential for the identification and elimination of RSV-infected airway epithelial cells. By triggering the release of cytotoxic molecules and antiviral cytokines like interferon-gamma, the TCR facilitates viral clearance and limits the spread of the infection within the respiratory tract. In the context of therapeutic development, the RSV-specific TCR is a primary focus for adoptive T-cell therapies (TCR-T) and vaccine design. Researchers aim to enhance or engineer T-cells expressing high-affinity TCRs to provide protection for vulnerable populations, such as infants and the elderly, who are at high risk for severe bronchiolitis and pneumonia. However, therapeutic modulation of this target must be carefully balanced to avoid immunopathology, where an overactive T-cell response leads to excessive lung tissue damage. Understanding the structural basis of TCR-peptide-MHC interactions remains vital for developing precise immunotherapies that can effectively combat RSV while minimizing adverse inflammatory effects.

Other names

RSV-specific CD8+ T-cell receptorMHC class I-restricted RSV-specific TCRRespiratory syncytial virus-reactive T-cell receptorRSV-peptide-HLA complex-specific TCR

The T-cell receptor (TCR) on CD8+ T-lymphocytes recognizes specific RSV-derived peptides (such as those from the Nucleoprotein or Fusion protein) presented by MHC class I molecules on the surface of infected cells. Upon binding, the TCR triggers a signaling cascade that leads to the release of cytotoxic granules (perforin and granzymes) and pro-inflammatory cytokines, resulting in the lysis of the virus-infected cell and inhibition of viral replication.